IQVIA Asia Pacific’s Post

Good report for CAR T cell therapy!!

By integrating Real-world evidence (RWE) into product development strategies, biotech and pharma companies can optimize patient care, enhance drug development and drive measurable outcomes. Discover how AscellaHealth is harnessing real-time data and making a difference with innovative RWE-driven solutions. https://lnkd.in/eYD34VE9 #AscellaHealth #Life Sciences #HealthcareInnovation #RealWorldEvidence #PatientOutcomes 

At the intersection of data and patient care, pharmaceutical manufacturers and payers are harnessing the power of Real-World Data (RWD) to make informed decisions that drive value, improve patient outcomes and ensure cost-effective care. Read more in AscellaHealth’s Pharma Perspectives article here: https://lnkd.in/eNxfuE72 #drugdevelopment #specialtypharmacy #patientoutcomes #commercialization #RWD

Amidst concerns around the IRA's impact on biopharma, a visionary plan is needed to streamline early-phase trials and empower mid-market and emerging companies. 💡 Our CEO, Dr. Harsha K Rajasimha, Ph.D., shares a revolutionary approach to efficiently managing clinical trials and navigating drug pricing controls. Discover how Jeeva Clinical Trials Inc.'s tech-driven trial system cuts costs, enhances efficiency, prioritizes patients and innovation, and champions breakthrough therapies for all conditions. 🌐💊 Learn more: https://hubs.la/Q02sX4Fh0 #healthtech #clinicaltrials #emergingbiopharma #IRA #jeevatrials

Pleased to share the release of the Deloitte 2024 Global Life Sciences Sector Outlook report. This is a must-read for those in the life sciences industry looking to understand emerging trends and opportunities within the sector; such as how GenAI can be utilised to accelerate drug discovery and reduce R&D costs. Link here: https://deloi.tt/4b7XEaO

The pharmaceutical, biotech, and medtech scenes have never been more dynamic. Today, I’m excited to join fellow professionals at the inspiring conference “AI & Digital Health: Demystifying Regulatory Challenges” hosted by Casebase Health This event aims to lead the way in AI-driven healthcare innovations and demystify the regulatory hurdles in this rapidly evolving field. Looking forward to learning more about pioneering AI excellence in healthcare. #AIinHealthcare #DigitalHealth #HealthcareInnovation #RegulatoryChallenges

As a #biotech #CEO, you lead with audacious #vision, chasing #cures and pushing the boundaries of #science. But the path to market is fraught with uncertainty - soaring development #costs, blind spots in early #efficacy, and the chilling #risk of clinical trial failures, while securing #funding can feel like a moonshot.   IAG, IMAGE ANALYSIS GROUP is your #imaging expert partner in planning and executing clinical trials, and commercializing clinical stage assets. By bringing years of expertise in radiology, strategic thinking and smart investments, we support drug development efforts through clinical trials to market entry.   Our biotech portfolio companies take advantage of a range of innovative R&D #solutions, risk-sharing #financing and partnership models, early visibility of study performance through #DYNAMIKA platform and tailored strategy for potential pharmaceutical #partnerships.   IAG will attend #JPM24 in San Francisco, USA, 8-11 January 2024. Schedule a meeting: bio-partnering@ia-grp.com, with Dr. Olga Kubassova, Julia O'Lynn, R.T. (R)(M)(MR), David Cattaneo, Michael Clark, Roughan Sheedy   #biotechceo #drugdevelopment #clinicaltrials #lifescience #innovation #pharmaceutical #healthcare #aihealthcare #digitalhealth #medtech #venturecapital #investments #marketleader #disruptivetechnology #earlystage #entrepreneur #biotechweek #efficacychallenges #patientrecruitment #clinicaltrialdropout #fundinggap #marketuncertainty #riskmanagement #drugdiscovery #personalizedmedicine #futureofhealthcare #breakthroughtherapy #lifesavingtreatment #unmetmedicalneeds #gotomarketstrategy #biotechpartner #lifesciencesuccess #drugcommercialization #nextgenmedicine

We at B2i Digital are pleased to present another video from our portfolio company, Unicycive Therapeutics (NASDAQ: UNCY), highlighting the importance of innovation in kidney disease. In the video, Unicycive’s EVP of Pharmaceutical & Business Operations, Pramod Gupta, PhD, discusses dialysis patients’ immense daily pill burden and the need for improved treatment options. As Pramod notes, Unicycive’s lead drug candidate has the potential to significantly reduce this burden down to just 1 pill 3 times per day. Beyond speaking on Unicycive’s promising pipeline, Pramod also shares perspectives on the company’s nimble, patient-focused culture and their drive to make an impact. As he puts it: “Failure is not an option for us.” We encourage you to watch this motivating inside look at the Unicycive team and mission: https://lnkd.in/eDtqhfVU With 20+ years of bringing new therapies to market at companies like Baxter, Bausch & Lomb, Spectrum, and now Unicycive, Pramod lends incredible expertise. We are proud to have Unicycive as a B2i Digital Featured Company, representing our commitment to spotlighting leaders in healthcare innovation. Featured Company Profile: https://lnkd.in/eg9U-h4f To learn more about Unicycive and other emerging healthcare companies, please visit the B2i Digital website. #biotech #medtech #entrepreneurship #leadership #patientimpact #raredisease #kidneydisease #innovation #pharmainnovation #B2iDigital

📢 Today's the Day! Join the insightful keynote on "𝙄𝙨 𝘼𝙄 𝙋𝙝𝙖𝙧𝙢𝙖’𝙨 𝙜𝙤𝙡𝙙𝙚𝙣 𝙥𝙞𝙡𝙡?" at HLTH Europe!     Explore how AI is reshaping pharmaceuticals from drug discovery to patient care with Bayer’s Chief Medical Officer, Mike Devoy MD, and other industry leaders ✨.    🕒 When: 𝐓𝐎𝐃𝐀𝐘, 2:20 𝐏𝐌 - 2:40 𝐏𝐌    📍 Where: Main Stage    Don't miss out on insights that could define the future of AI in Pharma! 🚀    #hltheurope #healthcare #digitalhealth #healthtech